ERYTECH PHARMA : ANNUAL GENERAL MEETING OF JUNE 24, 2016 Post author:admERY Post published:June 3, 2016 Post category:Newsroom Erytech announced today the modalities for making available the documents for the Annual General Meeting of June 24, 2016. You Might Also Like ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar April 28, 2022 ERYTECH reported full GRASPA® Phase III results in ALL and provided update on AML Phase IIb at ASCO June 1, 2015 ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar April 28, 2022
ERYTECH reported full GRASPA® Phase III results in ALL and provided update on AML Phase IIb at ASCO June 1, 2015
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016